Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Giovanna
Giovanna Antognetti, Foxboro, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20120003235 | ANTI-LYMPHOTOXIN ANTIBODIES - The instant invention is based, at least in part on the identification of a new class of antibodies that result, e.g., in improved LT blocking capabilities. Methods of making the subject binding molecules and methods of using the binding molecules of the invention to antagonize LTβR signaling are also provided. | 01-05-2012 |
Giovanna Assero, Catania IT
| Patent application number | Description | Published |
|---|---|---|
| 20090087453 | Virosome particles comprising antigens from influenza virus and hepatitis b virus - The present invention provides a virosome comprising a virosomal membrane comprising at least one lipid and envelope proteins of an enveloped virus and of the virosome and attached to said envelope proteins. Furthermore, the invention provides a vaccine comprising the virosome of the invention and, a method for the production of a virosome of the invention. Moreover, the invention provides a use of a virosome of the invention for the preparation of a vaccine, e.g. for the prevention or alleviation of a disease related to an HBV infection, and a method for the vaccination of a subject. | 04-02-2009 |
Giovanna Barbarella, Bologna IT
| Patent application number | Description | Published |
|---|---|---|
| 20090137789 | Oligonucleotide Probes - Fluorescent oligonucleotide probe having a general formula (I), wherein Onu represents an oligonucleotide residue, Thio | 05-28-2009 |
Giovanna Benefazio, Rome IT
| Patent application number | Description | Published |
|---|---|---|
| 20100057345 | SYSTEM AND METHOD FOR ITEM IDENTIFICATION, LOCATION AND NAVIGATION INSTRUCTION THERETO - A method and system for identifying, locating and providing navigational instructions among distributed items is disclosed. The method includes the steps of designating a plurality of items, identifying each of the items, accessing a data base to obtain at least location information associated with each identified item, providing a map of the location of each item, determining a distance to each item, determining a first item based on a user's position and sorting the list by distance with respect to the first item and providing navigational instructions to each item on the list. | 03-04-2010 |
Giovanna Bergamini Moore, Heidelberg DE
| Patent application number | Description | Published |
|---|---|---|
| 20100055711 | METHODS FOR THE IDENTIFICATION OF PI3K INTERACTING MOLECULES AND FOR THE PURIFICATION OF PI3K - The present invention relates to a method for the identification of a PI3K interacting compound, comprising the steps of a) providing a protein preparation containing PI3K, b) contacting the protein preparation with phenylthiazole ligand 1 immobilized on a solid support under conditions allowing the formation of a phenylthiazole ligand 1-PI3K complex, c) incubating the phenylthiazole ligand 1-PI3K complex with a given compound, and d) determining whether the compound is able to separate PI3K from the immobilized phenylthiazole ligand 1. Furthermore, the present invention relates to a method for the identification of a PI3K interacting compound, comprising the steps of a) providing a protein preparation containing PI3K, b) contacting the protein preparation with phenylthiazole ligand 1 immobilized on a solid support and with a given compound under conditions allowing the formation of a phenylthiazole ligand 1-PI3K complex, and c) detecting the phenylthiazole ligand 1-PI3K complex formed in step b). Furthermore, the present invention relates to a method for the identification of a PI3K interacting compound, comprising the steps of a) providing two aliquots of a protein preparation containing PI3K, b) contacting one aliquot with the phenylthiazole ligand 1 immobilized on a solid support under conditions allowing the formation of a phenylthiazole ligand 1-PI3K complex, c) contacting the other aliquot with the phenylthiazole ligand 1 immobilized on a solid support and with a given compound under conditions allowing the formation of a phenylthiazole ligand 1-PI3K complex, and d) determining the amount of the phenylthiazole ligand 1-PI3K complex formed in steps b) and c). Furthermore, the present invention relates to a method for the identification of a PI3K interacting compound, comprising the steps of a) providing two aliquots comprising each at least one cell containing PI3K, b) incubating one aliquot with a given compound, c) harvesting the cells of each aliquot, d) lysing the cells in order to obtain protein preparations, e) contacting the protein preparations with the phenylthiazole ligand 1 immobilized on a solid support under conditions allowing the formation of a phenylthiazole ligand 1-PI3K complex, and f) determining the amount of the phenylthiazole ligand 1-PI3K complex formed in each aliquot in step e). | 03-04-2010 |
| 20110111972 | SELECTIVITY PROFILING OF PI3K INTERACTING MOLECULES AGAINST MULTIPLE TARGETS - The present invention relates to methods wherein a PI3K interacting compound is identified by incubating a PI3K containing protein preparation with phenyl thiazole ligand 1. | 05-12-2011 |
Giovanna Boccardo, Anchorage, AK US
| Patent application number | Description | Published |
|---|---|---|
| 20110024115 | Method to Control Driving Fluid Breakthrough During Production of Hydrocarbons from a Subterranean Reservoir - The invention is directed to a method for controlling driving fluid breakthrough caused by zones of pressure communication, i.e., a matrix bypass event (“MBE”) or a wormhole, having a void space and possibly areas of enhanced permeability (a halo region) associated with the void space, within a subterranean formation arising from use of a driving fluid in reservoirs where heavy/viscous oil is being produced. In particular, the method is directed to remediation of pressure communication between injection and production wells used to produce heavy/viscous oil by way of a waterflood operation combined with a cold production method. Direct or rapid communication of water between the injector and producer wells makes the waterflood recovery process virtually ineffective and limits the production of oil from the reservoir. The invention comprises in embodiments a method wherein a slurry of a cementitious material is injected into the zone, which upon setting, provides a cement plug in the void space that reduces the pressure communication and flow of driving fluid within the zone. Another step is used to inject a gel precursor within the zone, which upon setting, produces a gel plug that also reduces pressure communication and driving fluid flow through the halo region of the zone. | 02-03-2011 |
Giovanna Cascardo, Villafranca D'Asti IT
| Patent application number | Description | Published |
|---|---|---|
| 20110206754 | IMPLANT DEVICE - The present description relates to an implant device, having an improved integration in the tissue of the animal or human body into which it is inserted, when compared to the prior art devices. | 08-25-2011 |
Giovanna Della Porta, Cava Dei Tirreni IT
| Patent application number | Description | Published |
|---|---|---|
| 20090071509 | Process for Cleaning Engraved Cylinders Used in Printing and Packaging Industry From Adhesive and/or Ink Residues - A process for the removal of dry adhesives and/or inks from the surface and from the interior of the cells of the engraved cylinders used in printing and coupling processes, using a supercritical mixture formed by one or more organic solvents and a supercritical fluid, preferably consisting of supercritical carbon dioxide. The microscopic cells of the engraved cylinders used in printing industry or of the cylinders used for film coupling in packaging industry are thoroughly and easily cleaned by a process comprising the steps of forming the said supercritical mixture, delivering it in a high pressure autoclave previously filled with the engraved cylinders to be cleaned, cleaning for a given residence time, eliminating the organic solvent residue in the autoclave by washing it with supercritical fluid and precipitating the extracted inks and/or adhesives in one or more separators located downstream the autoclave. | 03-19-2009 |
Giovanna Della Porta, Fisciano IT
| Patent application number | Description | Published |
|---|---|---|
| 20100203145 | CONTINUOUS PROCESS FOR MICROSPHERES PRODUCTION BY USING EXPANDED FLUIDS - The invention concerns a process for the continuous treatment of an emulsion and/or a micro-emulsion assisted by an “expanded liquid” for the production of micro- and/or nano-particles or micro- and/or nano-spheres containing one or more active ingredients. In particular, a liquid solvent expanded by compressed or supercritical CO | 08-12-2010 |
Giovanna Della Porta, Cava Dei Tirreni (sa) IT
| Patent application number | Description | Published |
|---|---|---|
| 20110192422 | PROCESS FOR CLEANING ENGRAVED CYLINDERS USED IN PRINTING AND PACKAGING INDUSTRY FROM ADHESIVE AND/OR INK RESIDUES - A process for the removal of dry adhesives and/or inks from the surface and from the interior of the cells of the engraved cylinders used in printing and coupling processes, using a supercritical mixture formed by one or more organic solvents and a supercritical fluid, preferably consisting of supercritical carbon dioxide. The microscopic cells of the engraved cylinders used in printing industry or of the cylinders used for film coupling in packaging industry are thoroughly and easily cleaned by a process comprising the steps of forming the said supercritical mixture, delivering it in a high pressure autoclave previously filled with the engraved cylinders to be cleaned, cleaning for a given residence time, eliminating the organic solvent residue in the autoclave by washing it with supercritical fluid and precipitating the extracted inks and/or adhesives in one or more separators located downstream the autoclave. | 08-11-2011 |
Giovanna Delogu, Sassari IT
| Patent application number | Description | Published |
|---|---|---|
| 20090130155 | Biologically Active Formulation - The present invention provides a formulation characterised by the simultaneous presence in cyclodextrin based supramolecular complexes, of two components, one of which possesses insecticidal, acaricidal, fungicidal, snailcidal or vermicidal activity and the other possesses an activity synergistic with the first, enhancing its effectiveness. The biologically active substance is chosen from the following classes of chemical products: carbamates, organophosphates, thioureas, pentatomic or hexatomic heterocycles in which 1, 2 or 3 nitrogen atoms are present. The synergistic substance can be chosen from components containing at least one aromatic or non aromatic carbocyclic ring, such as piperonyl butoxide, sesamol, verbutin or MGK 264. For the same dose, the activity of the present formulations is greater than that of the mixture of the two active components alone or separately complexed with cyclodextrin. The process for preparing said formulation and its use for the activities herein indicated are further aspects of the present invention. | 05-21-2009 |
Giovanna Del Sante, Busnago IT
| Patent application number | Description | Published |
|---|---|---|
| 20120125204 | Coffee Machine with Integrated Water Purification System - The present invention is directed to a coffee machine comprising a system, inside or outside the coffee machine, for the purification of water based on a membrane, directly fed by the pump of the coffee machine. The invention is also directed to a kit for coffee machine which comprises a system for the purification of water based on a membrane. | 05-24-2012 |
Giovanna Di Blasi, Castel Maggiore IT
| Patent application number | Description | Published |
|---|---|---|
| 20090130155 | Biologically Active Formulation - The present invention provides a formulation characterised by the simultaneous presence in cyclodextrin based supramolecular complexes, of two components, one of which possesses insecticidal, acaricidal, fungicidal, snailcidal or vermicidal activity and the other possesses an activity synergistic with the first, enhancing its effectiveness. The biologically active substance is chosen from the following classes of chemical products: carbamates, organophosphates, thioureas, pentatomic or hexatomic heterocycles in which 1, 2 or 3 nitrogen atoms are present. The synergistic substance can be chosen from components containing at least one aromatic or non aromatic carbocyclic ring, such as piperonyl butoxide, sesamol, verbutin or MGK 264. For the same dose, the activity of the present formulations is greater than that of the mixture of the two active components alone or separately complexed with cyclodextrin. The process for preparing said formulation and its use for the activities herein indicated are further aspects of the present invention. | 05-21-2009 |
Giovanna Fogliato, Barzana IT
| Patent application number | Description | Published |
|---|---|---|
| 20090093032 | PROCESS FOR PRODUCING 7-METHOXY-3-DESACETYLCEFALOTIN - Process for producing 7-methoxy-3-desacetylcefalotin by a hydrolysis process which takes place in water and is catalyzed by an enzyme. Cefoxitin can be obtained from this compound by known methods. | 04-09-2009 |
Giovanna Frugis, Rome IT
| Patent application number | Description | Published |
|---|---|---|
| 20100169997 | PROMOTION OF SOMATIC EMBRYOGENESIS IN PLANTS BY WUSCHEL GENE EXPRESSION - The present invention relates to methods for promoting somatic embryogenesis from a tissue or organ of a plant, by overexpressing a Wuschel gene in said tissue or organ. In one embodiment, such overexpression can be used as a silent selectable marker for transgenic plants. In another embodiment, such expression can be used to confer apomixis to a plant. In another embodiment, such overexpression can be used to create haploid plants, which can be used to produce dihaploid plants. | 07-01-2010 |
| 20110078823 | PROMOTION OF SOMATIC EMBRYOGENESIS IN PLANTS BY WUSCHEL GENE EXPRESSION - The present invention relates to methods for promoting somatic embryogenesis from a tissue or organ of a plant, by overexpressing a Wuschel gene in said tissue or organ. In one embodiment, such overexpression can be used as a silent selectable marker for transgenic plants. In another embodiment, such expression can be used to confer apomixis to a plant. In another embodiment, such overexpression can be used to create haploid plants, which can be used to produce dihaploid plants. | 03-31-2011 |
| 20110252506 | PROMOTION OF SOMATIC EMBRYOGENESIS IN PLANTS BY WUSCHEL GENE EXPRESSION - The present invention relates to methods for promoting somatic embryogenesis from a tissue or organ of a plant, by overexpressing a Wuschel gene in said tissue or organ. In one embodiment, such overexpression can be used as a silent selectable marker for transgenic plants. In another embodiment, such expression can be used to confer apomixis to a plant. In another embodiment, such overexpression can be used to create haploid plants, which can be used to produce dihaploid plants. | 10-13-2011 |
| 20120102594 | PROMOTION OF SOMATIC EMBRYOGENESIS IN PLANTS BY WUSCHEL GENE EXPRESSION - The present invention relates to methods for promoting somatic embryogenesis from a tissue or organ of a plant, by overexpressing a Wuschel gene in said tissue or organ. In one embodiment, such overexpression can be used as a silent selectable marker for transgenic plants. In another embodiment, such expression can be used to confer apomixis to a plant. In another embodiment, such overexpression can be used to create haploid plants, which can be used to produce dihaploid plants. | 04-26-2012 |
Giovanna La Rana, Napoli IT
| Patent application number | Description | Published |
|---|---|---|
| 20110212904 | GALACTOSYLATED PRO-DRUGS OF NON-STEROIDAL ANTI-INFLAMMATORIES WITH IMPROVED PHARMACOKINETIC CHARACTERISTICS AND REDUCED TOXICITY OF THE STARTING DRUG - Pro-drugs of all non-steroidal anti-inflammatories with free acid function derivatized with an ester group, which have the general structural formula given below (I) where A is: aspirin, diflunisal, benorylate, ibufenac, diclofenac, indomethacin, sulindac, ketorolac, ibuprofen, naproxen, ketoprofen, fenoprofen, flurbiprofen, mefenamic acid, meclof enamic acid, flufenamic acid, niflumic acid, and where in the ester group R can be a sugar (amongst which aldose, or ketose pentose, or esose selected from a group of D- and L-enantioiuers of ribose, glucose, galactose, mannose, arabinose, xilose, allose, altrose, gulose, idose and talose and substituted derivatives thereof, such as glucosamine, galactosamine, N-acetyl glucosamine, N-acetyl galactosamine, N-acetyl ribosamine), a disaccharide, a trisaccharide or an oligosaccharide. | 09-01-2011 |
Giovanna Larini, Torino IT
| Patent application number | Description | Published |
|---|---|---|
| 20100142692 | Method and system for providing teleassistance services based on software agents executing workflows - A system for performing a teleassistance service, for example, in the medical field, comprising a central system for controlling and managing the service, a local system for performing the service, and a telecommunication network adapted to communicate the central system with the local system, wherein the local system includes at least one sensor adapted to perform measures of at least one biomedical parameter on a user and a terminal adapted to communicate with the sensor for receiving information related to measure results and adapted to transmit said information to the central system through the telecommunications network, and wherein at least one between the terminal and the central system includes a software agent provided with a process engine for executing workflows, said agent being adapted to interact with the sensor when executing workflows. | 06-10-2010 |
Giovanna Laudisio, Bristol GB
| Patent application number | Description | Published |
|---|---|---|
| 20090298283 | CONDUCTIVE COMPOSITIONS AND PROCESSES FOR USE IN THE MANUFACTURE OF SEMICONDUCTOR DEVICES - ORGANIC MEDIUM COMPONENTS - Embodiments of the invention relate to a silicon semiconductor device, and a conductive paste for use in the front side of a solar cell device. | 12-03-2009 |
| 20100243048 | METAL PASTES AND USE THEREOF IN THE PRODUCTION OF SILICON SOLAR CELLS - Metal pastes comprising (a) at least one electrically conductive metal powder selected from the group consisting of silver, copper and nickel, (b) at least one lead-free glass frit with a softening point temperature in the range of 550 to 611° C. and containing 11 to 33 wt.-% of SiO | 09-30-2010 |
| 20100269893 | METAL PASTES AND USE THEREOF IN THE PRODUCTION OF POSITIVE ELECTRODES ON P-TYPE SILICON SURFACES - Metal pastes comprising (a) at least one electrically conductive metal powder selected from the group consisting of silver, copper, and nickel, (b) at least one p-type silicon alloy powder, and (c) an organic vehicle, wherein the p-type silicon alloy is selected from the group consisting of alloys comprising silicon and boron, alloys comprising silicon and aluminum and alloys comprising silicon, boron and aluminum. | 10-28-2010 |
| 20100294359 | PROCESS OF FORMING A GRID ELECTRODE ON THE FRONT-SIDE OF A SILICON WAFER - A process of forming a front-grid electrode on a silicon wafer having an ARC layer, comprising the steps: | 11-25-2010 |
| 20100294360 | PROCESS OF FORMING A GRID ELECTRODE ON THE FRONT-SIDE OF A SILICON WAFER - A process of forming a front-grid electrode on a silicon wafer having an ARC layer, comprising the steps: | 11-25-2010 |
| 20100294361 | PROCESS OF FORMING A GRID ELECTRODE ON THE FRONT-SIDE OF A SILICON WAFER - A process of forming a front-grid electrode on a silicon wafer having an ARC layer, comprising the steps: | 11-25-2010 |
| 20100317143 | PROCESS OF FORMING A SILICON SOLAR CELL - A process for the production of a silicon solar cell comprising application and firing of an aluminum paste which comprises magnesium oxide and/or magnesium compounds capable of forming magnesium oxide on firing on the back-side of a silicon wafer provided with a silicon nitride antireflective coating on its front-side and being contaminated with silicon nitride on its back-side, and firing the aluminum paste after its application. | 12-16-2010 |
| 20110120551 | PROCESS FOR THE FORMATION OF A SILVER BACK ELECTRODE OF A PASSIVATED EMITTER AND REAR CONTACT SILICON SOLAR CELL - A process for the formation of an electrically conductive silver back electrode of a PERC silicon solar cell comprising the steps: | 05-26-2011 |
| 20110139238 | PROCESS FOR THE PRODUCTION OF A MWT SILICON SOLAR CELL - A process for the production of a MWT silicon solar cell comprising the steps: | 06-16-2011 |
| 20110146776 | GLASS COMPOSITIONS USED IN CONDUCTORS FOR PHOTOVOLTAIC CELLS - The invention relates to glass compositions useful in conductive pastes for silicon semiconductor devices and photovoltaic cells. | 06-23-2011 |
| 20110146781 | PROCESS OF FORMING A GRID CATHODE ON THE FRONT-SIDE OF A SILICON WAFER - A process for the production of a grid cathode on the front-side of a silicon wafer by applying and firing a metal paste on the silicon wafer in a front-side grid electrode pattern to form a seed grid cathode and subsequently subjecting the silicon wafer to a LIP process, wherein the metal paste comprises an organic vehicle and an inorganic content comprising (a) 90 to 98 wt.-% of at least one electrically conductive metal powder selected from the group consisting of nickel, copper and silver, and (b) 0.25 to 8 wt.-% of at least one glass frit selected from the group consisting of glass frits containing 47.5 to 64.3 wt.-% of PbO, 23.8 to 32.2 wt.-% of SiO | 06-23-2011 |
| 20110192456 | PROCESS FOR THE PRODUCTION OF A MWT SILICON SOLAR CELL - A process for the production of a MWT silicon solar cell comprising the steps: | 08-11-2011 |
| 20110240124 | METAL PASTES AND USE THEREOF IN THE PRODUCTION OF SILICON SOLAR CELLS - Metal pastes comprising (a) at least one electrically conductive metal powder selected from the group consisting of silver, copper and nickel, (b) at least one lead-containing glass frit with a softening point temperature in the range of 571 to 636° C. and containing 53 to 57 wt.-% of PbO, 25 to 29 wt.-% of SiO | 10-06-2011 |
Giovanna Libralon, Veneta IT
| Patent application number | Description | Published |
|---|---|---|
| 20110028726 | METHOD FOR PREPARING ARGATROBAN MONOHYDRATE AND A PROCESS FOR ITS SYNTHESIS - A method is described for preparing argatroban monohydrate obtained from (2R,4R)-1-[N | 02-03-2011 |
Giovanna Luoni, Cardano Al Campo IT
| Patent application number | Description | Published |
|---|---|---|
| 20100160411 | BENZOXATHIINE AND BENZOXATHIOLE DERIVATIVES AND USES THEREOF - Compounds of formula (I) or pharmaceutically acceptable salts thereof are provided, wherein each of R | 06-24-2010 |
Giovanna Marrapese, Mailand IT
| Patent application number | Description | Published |
|---|---|---|
| 20090269344 | Anti-EGFR antibody therapy based on an increased copy number of the EGFR gene in tumor tissues - The invention relates to an indidualized and personalized diagnosis and therapy of cancer based on specific molecular alterations which occur in specific tumor tissue of specific tumor patient populations. The therapy and diagnostic is based on the findings that proliferation and tumor growth of specific EGFR bearing tumor tissue expressing an amplified EGFR gene copy number may be abolished by anti-EGFR antibodies, while other individual molecular alterations such as mutations occurring in tumor tissues are unaffected by the same anti-EGFR antibody treatment. | 10-29-2009 |
Giovanna Melcarne, Gagliano Del Capo IT
| Patent application number | Description | Published |
|---|---|---|
| 20100316561 | PROCESS FOR THE PREPARATION OF TITANIUM DIOXIDE WITH NANOMETRIC DIMENSIONS AND CONTROLLED SHAPE - The present invention relates to an industrial applicable process for the preparation of materials with nanometric dimensions and controlled shape, based on titanium dioxide. The invention also relates to a process for the preparation of titanium dioxide nanorods with anatase phase composition, which are highly suitable for applications involving photovoltaic cells, particularly Dye Sensitized Solar Cells (DSSC), photoelectrolysis cells and tandem cells for the conversion of solar energy and the production of hydrogen. | 12-16-2010 |
Giovanna Mencarelli, Norfolk GB
| Patent application number | Description | Published |
|---|---|---|
| 20110111108 | COMPOSITIONS AND METHOD FOR ASSISTING SWALLOWING - A method of assisting a subject to swallow an object such as a solid pharmaceutical dosage form comprises providing on the object an at least partial surface covering comprising a lubricating edible gel composition. | 05-12-2011 |
Giovanna Palamone, Alessandria IT
| Patent application number | Description | Published |
|---|---|---|
| 20110040039 | TETRAFLUOROETHYLENE POLYMER PARTICLES - Core-shell particles having a core of at least one tetrafluoroethylene (TFE) polymer and having an average primary particle size of less than 50 nm; and a shell of at least one acrylic polymer having recurring units, more than 50% by moles of which being derived from at least one ethylenically unsaturated monomer having directly bonded to one of the sp | 02-17-2011 |
Giovanna Palombo, Napoli IT
| Patent application number | Description | Published |
|---|---|---|
| 20100297003 | Anti-human tenascin monoclonal antibody - An anti-human tenascin monoclonal antibody is described, whose light and heavy chain variable region sequences are SEQ ID 1 and SEQ ID 2, respectively, its proteolytic fragments capable of binding to an antigenic epitope within the region A | 11-25-2010 |
Giovanna Pitarresi, Palermo IT
| Patent application number | Description | Published |
|---|---|---|
| 20080292664 | Hydrogels and Hyaluronic Acid and Alpha, Beta-Polyaspartyl-Hydrazide and Their Biomedical and Pharmaceutical Uses - Compositions and products based on the chemical crosslinking of hyaluronic acid with a polyfunctional polymer having a protein-like structure, bearing hydrazido pendent groups along the polymeric chain. The polymer is preferably, alpha-beta-polyaspartylhydrazide, a biocompatible macromolecule. The materials obtained after crosslinking, specifically hydrogels, undergo a reduced chemical and enzymatic degradation, unlike the starting hyaluronic acid, and they can be used to prepare systems for applications in the biomedical and pharmaceutical field. | 11-27-2008 |
| 20110236486 | METHOD TO PRODUCE HYALURONIC ACID FUNCTIONALIZED DERIVATIVES AND FORMATION OF HYDROGELS THEREOF - A system and method are provided for controlling an internal combustion engine driving a generator/welder or a stand-alone generator. Controlling the engine may include altering the engine speed based upon a detected demand on the generator and/or operating parameters of a welder. For example, the engine speed may be increased based on a detected draw on the generator and/or the operating parameters of the welder. In addition, the engine speed may be automatically decreased to a non-standard idle speed or the engine may be automatically turned off if no demand is detected for a period of time. Additionally, the engine speed may be increased if only frequency-insensitive demands are detected on the generator. Combinations of these and further methods may be executed. Various devices are provided for implementing the above methods. | 09-29-2011 |
| 20110280921 | ANTIBACTERIAL HYDROGEL AND USE THEREOF IN ORTHOPEDICS - The present invention relates to hydrogels endowed with antibacterial properties, to be used for injection in damaged bones or in the production of antibacterial coatings of prostheses for implant in the human or animal body, obtained by loading with antibacterial agents hydrogels formed by derivatives of hyaluronic acid; the invention also relates to a kit of parts for producing the antibacterial hydrogels. | 11-17-2011 |
Giovanna Pressi, Monteforte D'Alpone (verona) IT
| Patent application number | Description | Published |
|---|---|---|
| 20110123646 | Extracts Obtained from Cell Line Cultures from Plants Belonging to the Oleaceae Family (e.g. Syringa Vulgaris), Their Preparation and Use - The present invention refers to the use of extracts from selected and stabilised cell lines comprising phenylpropanoids with high anti-oxidant capacity having a verbascoside titre of between 20% and 90% and a chromophore-free fraction of between 80% and 10%, in human and veterinary medicine, and for nutritional and cosmetic purposes. | 05-26-2011 |
Giovanna Salzillo, Teverola IT
| Patent application number | Description | Published |
|---|---|---|
| 20090322212 | SYNTHESIS OF NEW ORGANIC MATERIAL FOR POLYMERIC LIGHT EMITTING DIODE - New, highly photoluminescent compounds are described having structural formula (I) | 12-31-2009 |
| 20100127250 | METHOD FOR REALIZING A THIN FILM ORGANIC ELECTRONIC DEVICE AND CORRESPONDING DEVICE - A method realizes a thin film organic electronic device integrated on a substrate and includes an organic material layer and an organic thin film transistor or OTFT transistor. The method comprises: depositing the organic material layer on the substrate, the organic material layer being a conductive organic polymer; patterning by a soft-lithographic procedure the organic material layer to create a reduced portion in order to make a channel area of the OTFT transistor; masking the organic material layer by covering with a cover mask a source area and a drain area of the OTFT transistor; irradiating by ultraviolet radiation to deactivate exposed portions of the organic material layer defining the source area, the drain area and the channel area; depositing on the organic material layer a semiconductor layer; and creating on the semiconductor layer a gate area of the OTFT transistor. | 05-27-2010 |
Giovanna Sotgiu, Ozzano Dell'Emilia IT
| Patent application number | Description | Published |
|---|---|---|
| 20090137789 | Oligonucleotide Probes - Fluorescent oligonucleotide probe having a general formula (I), wherein Onu represents an oligonucleotide residue, Thio | 05-28-2009 |
Giovanna Tosato, Bethesda, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20080260687 | SPECIFIC BINDING AGENTS FOR KSHV vIL-6 THAT NEUTRALIZE A BIOLOGICAL ACTIVITY - A specific binding agent is provided, wherein the specific binding agent specifically binds Kaposi's sarcoma-associated herpesvirus (KSHV) interleukin-6 (vIL-6), and the specific binding agent neutralizes an activity of vIL-6. In one embodiment, the specific binding agent is an antibody. Methods are provided for using a specific binding agent that binds vIL-6, and neutralizes a biological activity of vIL-6. Methods of treatment for a KSHV-associated disorder are also provided. Methods for diagnosing a KSHV-associated disorder are provided, as are kits that include a specific binding agent of the invention. A method is also provided for testing an agent for effectiveness in treating a KSHV-associated disorder. The method includes incubating the agent with a cell free system comprising a vIL-6 receptor component and vIL-6, and comparing the binding of vIL-6 and the receptor component in the presence of the agent to binding of vIL-6 to the receptor component in the absence of the agent. A decrease in the binding of vIL-6 to the receptor component in the presence of the agent indicates that the agent is effective for treating the KSHV-associated disorder. | 10-23-2008 |
| 20090149380 | VASOSTATIN AS MARROW PROTECTANT - Specific fragments of vasostatin are disclosed. These fragments are of use in methods of stimulating the proliferation or survival of a hematopoietic cell exposed to a chemotherapeutic agent or irradiation. Methods of stimulating the proliferation or survival of a hematopoietic cell using these fragments are also disclosed. In one embodiment, methods are disclosed for stimulating the growth or survival of a hematopoietic stem cell with a fragment of vasostatin, in the presence of a growth factor. | 06-11-2009 |
| 20100297124 | INDUCED INTERNALIZATION OF SURFACE RECEPTORS - Disclosed is a hetero-bifunctional ligand for use in inducing internalization of a target receptor. The hetero-bifunctional ligand includes a target receptor-binding agent that specifically binds the target receptor linked to an internalizing receptor-binding agent that specifically binds to an internalizing receptor, where the two binding agents are non-identical. Also disclosed is a method of inducing the internalization of a target receptor on a cell. The method includes contacting a cell with a hetero-bifunctional ligand, where binding of the hetero-bifunctional ligand induces internalization of a target receptor of the cell. Also disclosed a method of treating a disease or condition associated with a target receptor using the disclosed hetero-bifunctional ligand and pharmaceutical compositions including a hetero-bifunctional ligand. | 11-25-2010 |
Giovanna Wagenaar Cacciola, Eindhoven NL
| Patent application number | Description | Published |
|---|---|---|
| 20080215124 | Apparatus for Cosmetic Skin Rejuvenation Treatment - The present invention relates to an apparatus for cosmetic skin rejuvenation treatment, comprising a continuous wave light source accommodating a high-intensity discharge lamp ( | 09-04-2008 |
| 20080255547 | Uv Lamp for Treatment of the Skin - UV lamp for treatment of the skin, which lamp has a radiation capacity substantially entirely in the UV spectrum and in the red-light spectrum, wherein the radiation capacity of the lamp in the red light spectrum between 600 nm and 700 nm is at least 3% of the radiation capacity in the UV spectrum. In a first embodiment the lamp is a UV fluorescent lamp, having a first UV emitting phosphor and a second red light emitting phosphor, wherein the red light emitting phosphor is CeGdMgB | 10-16-2008 |
| 20090005838 | TANNING APPARATUS - Indoor tanning, especially in commercial establishments which provide tanning beds, has been a very popular endeavour for the last few decades, particularly in view of concerns for exposure to natural sunlight and ultra-violet (UV) light. The invention relates to an improved tanning apparatus, having multiple light sources ( | 01-01-2009 |
| 20100179622 | SKIN TREATMENT DEVICE, LAMP AND USE - The invention relates to a skin treatment device, a lamp for use in such a skin treatment device, and its use. The skin treatment device according to the invention uses a combination of tanning-effective and/or anti-acne effective amounts of blue light in the spectral range from 400-440 nm in addition to the UV-light known in the art. An important advantage is that a lower UV dose can be used, leading to lower health risks, while the exposure times can be kept within acceptable limits, without compromising the skin treatment result. | 07-15-2010 |
| 20120101557 | TREATMENT APPARATUS AND USE THEREOF FOR TREATING PSORIASIS - A treatment apparatus ( | 04-26-2012 |
Giovanna Wagennar Cacciola, Eindhoven NL
| Patent application number | Description | Published |
|---|---|---|
| 20100010593 | SYSTEM OF PLASTER AND RADIATION DEVICE - The invention relates to a compact, comfortably wearable system ( | 01-14-2010 |
Giovanna Zarba, Torino IT
| Patent application number | Description | Published |
|---|---|---|
| 20090028059 | Method and System for Simulating a Communication Network, Related Network and Computer Program Product Therefor - A simulator system for simulating a wireless local area network in a combination of a wireless local area network and one or more 2G or 3G mobile communication networks includes a first set and a second set of access protocol simulation devices representative of wireless local area network apparatus implementing access protocols. The first set of access protocol simulation devices is representative of radio technology independent apparatus providing integration of the wireless local area network with the mobile communication network(s). The second set of access protocol simulation devices is representative of radio technology dependent apparatus present in the wireless local area network. The simulator is thus configured for simulating different types of wireless local area network technology in the wireless local area network by varying the access protocol simulation devices in the second set while maintaining the access protocol simulating devices in the first set. | 01-29-2009 |